Suppr超能文献

精确原位递送光增强型炎症小体激活纳米疫苗可激活抗肿瘤免疫。

Precise In Situ Delivery of a Photo-Enhanceable Inflammasome-Activating Nanovaccine Activates Anticancer Immunity.

机构信息

State Key Laboratory of Pharmaceutical Biotechnology, Dr. Li Dak-Sum Research Centre, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China.

Department of Pancreato-Biliary Surgery and Liver Transplantation Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.

出版信息

Cancer Res. 2024 Nov 15;84(22):3834-3847. doi: 10.1158/0008-5472.CAN-24-0220.

Abstract

A variety of state-of-the-art nanovaccines (NV) combined with immunotherapies have recently been developed to treat malignant tumors, showing promising results. However, immunosuppression in the tumor microenvironment (TME) restrains cytotoxic T-cell infiltration and limits the efficacy of immunotherapies in solid tumors. Therefore, tactics for enhancing antigen cross-presentation and reshaping the TME need to be explored to enhance the activity of NVs. Here, we developed photo-enhanceable inflammasome-activating NVs (PIN) to achieve precise in situ delivery of a tumor antigen and a hydrophobic small molecule activating the nucleotide-binding oligomerization domain, leucine-rich repeat, and pyrin domain-containing protein 3 inflammasome (NLRP3) pathway. Near-infrared light irradiation promoted PIN accumulation in tumor sites through photo-triggered charge reversal of the nanocarrier. Systematic PIN administration facilitated intratumoral NLRP3 inflammasome activation and antigen cross-presentation in antigen-presenting cells upon light irradiation at tumor sites. Furthermore, PIN treatment triggered immune responses by promoting the production of proinflammatory cytokines and activating antitumor immunity without significant systematic toxicity. Importantly, the PIN enhanced the efficacy of immune checkpoint blockade and supported the establishment of long-term immune memory in mouse models of melanoma and hepatocellular carcinoma. Collectively, this study reports a safe and efficient photoresponsive system for codelivery of antigens and immune modulators into tumor tissues, with promising therapeutic potential. Significance: The development of a photoresponsive nanovaccine with spatiotemporal controllability enables robust tumor microenvironment modulation and enhances the efficacy of immune checkpoint blockade, providing an effective immunotherapeutic strategy for cancer treatment. See related commentary by Zhen and Chen, p. 3709.

摘要

多种最先进的纳米疫苗(NV)与免疫疗法相结合,最近已被开发用于治疗恶性肿瘤,显示出有前景的结果。然而,肿瘤微环境(TME)中的免疫抑制限制了细胞毒性 T 细胞的浸润,并限制了免疫疗法在实体瘤中的疗效。因此,需要探索增强抗原交叉呈递和重塑 TME 的策略,以增强 NV 的活性。在这里,我们开发了光增强的炎性小体激活 NV(PIN),以实现肿瘤抗原和疏水分子的精确原位递呈,该分子可激活核苷酸结合寡聚结构域、富含亮氨酸重复和吡喃结构域的蛋白 3 炎性小体(NLRP3)途径。近红外光照射通过纳米载体的光触发电荷反转促进 PIN 在肿瘤部位的积累。系统的 PIN 给药促进了肿瘤部位 NLRP3 炎性小体的激活和抗原交叉呈递,从而导致肿瘤部位的光照射。此外,PIN 处理通过促进促炎细胞因子的产生和激活抗肿瘤免疫来触发免疫反应,而没有明显的系统毒性。重要的是,PIN 增强了免疫检查点阻断的疗效,并支持在黑色素瘤和肝细胞癌的小鼠模型中建立长期免疫记忆。总之,这项研究报告了一种安全有效的光响应系统,可将抗原和免疫调节剂共递送至肿瘤组织,具有有前景的治疗潜力。意义:具有时空可控性的光响应纳米疫苗的开发实现了强大的肿瘤微环境调节,并增强了免疫检查点阻断的疗效,为癌症治疗提供了有效的免疫治疗策略。请参阅 Zhen 和 Chen 的相关评论,第 3709 页。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29e7/11565167/9e04b0d1fcf9/can-24-0220_ga.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验